Tel: +44 (0)20 7377 0800
Fax: +44 (0)20 7349 5157
Tel: +81 (0)80-1164-4754
Request a Demo
What our customers are saying
When I think of the future, I think of EvaluatePharma
Global pharmaceutical company
Evaluate and EP Vantage
Vice President Marketing, Evaluate
Chempetitive Group (for US media)
Instinctif Partners (for non-US media)
Melanie Toyne Sewell
+44 (0) 20 7457 2020
+44 (0) 7581 120 978
Evaluate is the trusted source for life science market intelligence and analysis with exclusive consensus forecasts to 2022. Our subscription services include EvaluatePharma, EvaluateClinical Trials and EvaluateMedTech. Evaluate Custom Services provides project-based analytical and data services. Our award-winning editorial team, EP Vantage, leverages our strategic analysis to cut through the noise, giving you daily opinion and insights. The Evaluate services enable the life science community to make sound business decisions about value and opportunity. For more information please visit: www.evaluate.com.
LinkedIn: Evaluate Company Page
To access our Evaluate Market Movers and Shakers Monthly Newsletter, a monthly round-up of upcoming events impacting company valuations, click here.
To source our reports please use the following formats. All of our complimentary reports can be found on our News and Insights page. Contact: Christine Lindgren with any questions.
Source: 2016, EvaluatePharma® [Report Name], Evaluate Ltd, www.evaluate.com
Source: 2016, EvaluateMedTech® [Report Name], Evaluate Ltd, www.evaluate.com